CPT code 84704 denotes laboratory quantitation of the free beta subunit of human chorionic gonadotropin (free beta hCG), a first-trimester biomarker used in prenatal screening for chromosomal abnormalities such as Down syndrome. Nationally, this test is a component of prenatal aneuploidy risk assessment and influences diagnostic follow-up, counseling, and care pathways for pregnant patients. Coverage and utilization of this test affect screening programs, prenatal clinical workflows, and laboratory operations across payers.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication reviews typical coverage considerations, common billing modifiers, and where CPT code 84704 fits in prenatal screening panels.

Readers will find concise benchmarks for clinical context and billing practice, an explanation of the test’s role in first-trimester screening, and a summary of payer considerations and common operational implications for laboratories and clinicians. Data not available in the input for payer-specific rates, ICD-10 pairings, and associated taxonomies is noted where applicable.